New Key Statistics Module, Z-Score and F-Score
TSXV:RX Key Ratios
Market Cap C$ M | 106.47 |
Enterprise Value C$ M | 83.96 |
P/E(ttm) | 15.36 |
PE Ratio without NRI | 15.33 |
Forward PE Ratio | 18.12 |
Price/Book | 3.03 |
Price/Sales | 3.30 |
Price/Free Cash Flow | 15.54 |
Price/Owner Earnings | 14.71 |
Payout Ratio % | 0.28 |
Revenue (TTM) C$ M | 32.00 |
EPS (TTM) C$ | 0.59 |
Beneish M-Score | -1.64 |
10-y EBITDA Growth Rate % | 12.10 |
5-y EBITDA Growth Rate % | 9.40 |
y-y EBITDA Growth Rate % | 37.60 |
EV-to-EBIT | 8.92 |
EV-to-EBITDA | 8.51 |
PEG | 1.63 |
Shares Outstanding M | 11.59 |
Net Margin (%) | 21.48 |
Operating Margin % | 24.89 |
Pre-tax Margin (%) | 28.44 |
Quick Ratio | 6.37 |
Current Ratio | 7.72 |
ROA % (ttm) | 17.53 |
ROE % (ttm) | 20.70 |
ROIC % (ttm) | 66.79 |
Dividend Yield % | 1.83 |
Altman Z-Score | 14.91 |
TSXV:RX Number of Guru Trades
TSXV:RX Volume of Guru Trades
Gurus Latest Trades with TSXV:RX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
TSXV:RX is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Biosyent Inc Insider Transactions
No Available Data